Use of SMSs to Improve Attendance to Cervical Cancer Follow-up Screening

December 28, 2021 updated by: Marianne Andersen

Text Messages to Increase Attendance to Follow-up Cervical Cancer Screening Appointments Among HPV Positive Tanzanian Women (Connected2Care)

This study evaluates the effect of the SMS intervention 'Connected2Care' on the attendance rate to cervical cancer screening follow-up appointments.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Connected2Care is a non-blinded, multicentre, parallel-group, randomised controlled trial. Tanzanian Women testing positive to HR HPV at inclusion are randomly assigned in an allocation ratio of 1:1 to the SMS intervention or the control group (standard care). In a period of 10 months, the intervention group will receive 15 one-directional health educative text messages and SMS-reminders for their appointment. The total sample size will be 700 with 350 women in each study arm. Primary outcome is attendance rate for follow-up. Secondary objectives are cost-effectiveness measured through incremental ratios and knowledge of cervical cancer by a 16-item true/false scale questionnaire at baseline and follow-up.

Study Type

Interventional

Enrollment (Actual)

705

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dar es Salaam, Tanzania, 3592
        • Ocean Road Cancer Institute (ORCI)
      • Moshi, Tanzania, 3010
        • Kilimanjaro Christian Medical Centre (KCMC)
    • Kilimanjaro
      • Moshi, Kilimanjaro, Tanzania
        • Mawenzi Regional Referral Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Informed consent
  • HPV positive
  • Age 25 - 60 years
  • Private mobile phone

Exclusion Criteria:

  • Pregnant on day of enrolment
  • Menstruating on day of enrolment
  • Hysterectomy
  • Diagnosed with cervical pre-cancer within past 12 months
  • Diagnosed with cervical cancer
  • Invalid mobile phone number
  • Unreachable when trying to convey HPV positive result

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Connected to Care
The SMS intervention will consist of 15 text messages that will be sent to the intervention group over a period of 10 months. There will be two types of text messages: (1) educational text messages; and (2) SMS reminders for the follow-up appointment.
10 health educative SMSs' sent once a month 5 SMS-reminders for follow-up appointment sent on days -14, -7, -1 pre- follow-up appointment, and +1, +7 post follow-up appointment
No Intervention: Control
The control group will receive standard care, which is a follow-up appointment at 14 months written on an appointment card.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of SMS intervention on attendance rate to follow-up screening appointment
Time Frame: up to 14 months
The effect measure of the intervention is the 14-month follow-up attendance rate for HPV positive women. The number of women in the intervention group that attend follow-up screening will be compared to the the number of women that attend follow-up screening in the control group.
up to 14 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of text message intervention
Time Frame: Baseline + 2 years Follow-up (likert scale)
6-point Likert scale (1: I do not like it at all - 6: I like it very much)
Baseline + 2 years Follow-up (likert scale)
Acceptability of text message intervention
Time Frame: 2 years
Qualitative interviews. Open-ended
2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-effectiveness of intervention
Time Frame: Baseline + 14 months
Incremental cost-effectiveness ratio
Baseline + 14 months
Knowledge of cervical cancer and screening
Time Frame: Baselie + 14 months
16 item true-false questionaire
Baselie + 14 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Vibeke Rasch, MD, University of Southern Denmark
  • Study Chair: Julius Mwaiselage, MD, Ocean Road Cancer Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2015

Primary Completion (Actual)

October 6, 2019

Study Completion (Actual)

October 6, 2019

Study Registration Dates

First Submitted

June 15, 2015

First Submitted That Met QC Criteria

July 25, 2015

First Posted (Estimate)

July 28, 2015

Study Record Updates

Last Update Posted (Actual)

December 29, 2021

Last Update Submitted That Met QC Criteria

December 28, 2021

Last Verified

December 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Cancer

Clinical Trials on Connected to Care

Subscribe